As part of our role in facilitating international collaborations, we would like to introduce one of our clients – an India-based AI driven research company specializing in developing agentic workflow systems to accelerate drug discovery and development. Their platform integrates autonomous decision-making with molecular design and simulation pipelines, enabling adaptive and efficient R&D outcomes. Their product suite includes a discovery phase platform offering:
1. De novo protein design
2. De novo small molecule design
3. Custom synthesis planning
In addition, their Clinical research platform optimizes clinical trial protocols. The Indian company already collaborates with leading pharma and cosmetics company, R&D centers and academic institutions globally. They are looking for innovation agencies and incubation hubs and clusters that in turn have a cohort of companies, AI-Driven pharma companies and Big Technology corporations which can use their product. In terms of academic collaborations, the Indian partner is planning to collaborate with research universities in the EU to give customized training programs to the students as well as use their platform planning to augment their career in AI and Drug Discovery where the client will serve as the industrial partner. We kindly request your support for this Indian company to suitable stakeholders, end-users, or potential collaborators within your network. Please reach out to Dr. Debayan Bose ([email protected]) or Mr. Harsha Lingam ([email protected]) for queries or connects with the company.